Get started Log in

GNTA — Genenta Science SpA Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Brief: Genenta Science SPA Milan Tribunal Issues Interim Order Suspending Board Appointment Resolution From June 29 Shareholders' Meeting - SEC Filing
22/10/2026 23:08
Brief: Genenta Science Announces Receipt Of Nasdaq Minimum Bid Price Deficiency Notification
21/10/2026 23:10
Brief: Genenta Science Court Of Milan Denies Interim Suspension Of Atc Capital Increase
07/10/2026 23:52
Brief: Genenta & Anemocyte Announce Strategic Partnership To Advance Off-The-Shelf LVV Plasmid Dna Production
24/10/2025 09:33
Brief: Genenta Science SpA -Entered Amendment To ATM Sales Agreement Dated April 26
20/12/2024 21:50
Brief: Genenta To Provide Update On Lead Product Temferon™
16/05/2023 12:06
Genenta Science rises on FDA's "orphan drug" tag for brain cancer drug
02/03/2023 16:31
Brief: FDA Grants Orphan Drug Designation To Brain Cancer Treatment
02/03/2023 12:56
Brief: Genenta Science And Agc Biologics Enter Development And Manufacturing Service Agreement
07/02/2023 12:06
NASDAQ RESUMED AT 10:18 AM
28/06/2022 15:18
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:10 AM
28/06/2022 15:11
NASDAQ RESUMED AT 10:10 AM
28/06/2022 15:10
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
28/06/2022 14:40
NASDAQ RESUMED AT 03:47 PM
23/06/2022 20:47
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:42 PM
23/06/2022 20:44
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:00 AM
16/03/2022 14:00
NASDAQ RESUMED AT 09:54 AM
16/03/2022 13:54
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
16/03/2022 13:35
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:56 AM
09/03/2022 14:57
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
07/03/2022 14:31